Circulating miRNAs Expression in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Area of Science:

• Biomarkers
• Epigenetics
• Virology

Background:

• Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease with unknown etiology and a lack of diagnostic biomarkers.
• Herpesviruses, such as HHV-6A and HHV-6B, are implicated as potential triggers in ME/CFS.
• MicroRNAs (miRNAs) are epigenetic regulators whose expression is affected by viral infections and may play a role in ME/CFS pathogenesis.

Purpose of the Study:

• To investigate the role of eight selected miRNAs as potential circulating biomarkers for ME/CFS.
• To quantitatively assess the expression levels of these miRNAs in ME/CFS patients compared to healthy controls.

Main Methods:

• Plasma samples from 40 ME/CFS patients and 20 healthy controls were analyzed.
• Quantitative detection of eight specific miRNAs was performed using Taqman assays.
• Correlation analyses were conducted between miRNA levels, disease severity, pro-inflammatory cytokines, and HHV-6A/6B genome presence.

Main Results:

• Six out of eight selected miRNAs exhibited differential expression in ME/CFS patients.
• Five miRNAs (miR-127-3p, miR-142-5p, miR-143-3p, miR-150-5p, miR-448) were significantly upregulated, and one (miR-140-5p) was downregulated.
• MiRNA levels correlated with ME/CFS disease severity but not with pro-inflammatory cytokines or HHV-6A/6B viral load.

Conclusions:

• The study identifies specific miRNAs as potential circulating biomarkers for ME/CFS diagnosis.
• These findings contribute to understanding the complex molecular pathways involved in ME/CFS development.
• Further validation studies are warranted to confirm the utility of miRNAs as ME/CFS biomarkers.